Ocular Therapeutix Inc (OCUL)

Shares of Ocular Therapeutix Inc (OCUL) dropped by 3.81% from $3.94 to $3.79 in the trading on Thursday, December 14, 2023. The reason why OCUL down today is due to OCUL's announcement of a public offering in which it priced 3,725,000 shares of its common stock at $21.50 per share, aiming to raise approximately $80.1 million. The company also granted underwriters a 30-day option to purchase up to an additional 558,750 shares on the same terms. The offering was expected to close around December 18, 2020, subject to customary closing conditions. Jefferies LLC and Piper Sandler & Co. were the joint book-running managers for the offering, with Raymond James & Associates, Inc. and JMP Securities LLC serving as co-managers. The offering complied with a shelf registration statement on Form S-3, which became effective upon filing with the Securities and Exchange Commission (SEC).